488
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Xenobiotic-induced liver injury and fibrosis

& , MD (Professor and Chair of Gastroenterology and Hepatology)
Pages 571-580 | Published online: 28 Mar 2012

Bibliography

  • Marschall HU, Wagner M, Zollner G, Trauner M. Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors. Mol Pharm 2007;4(6):895-910
  • Penz-Osterreicher M, Osterreicher CH, Trauner M. Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol 2011;25(2):245-58
  • Nagao K, Kimura Y, Mastuo M, Ueda K. Lipid outward translocation by ABC proteins. FEBS Lett 2010;584(13):2717-23
  • Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology 2011;53(4):1377-87
  • Davies MH, Harrison RF, Elias E, Hubscher SG. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994;20(1):112-16
  • Moradpour D, Altorfer J, Flury R, Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 1994;20(6):1437-41
  • Kopelman H, Robertson MH, Sanders PG, Ash I. The Epping jaundice. Br Med J 1966;1(5486):514-16
  • Zhang X, Lambert JC, Doll MA, 4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat. J Pharmacol Exp Ther 2006;316(1):289-94
  • Kanz MF, Dugas TR, Liu H, Santa Cruz V. Glutathione depletion exacerbates methylenedianiline toxicity to biliary epithelial cells and hepatocytes in rats. Toxicol Sci 2003;74(2):447-56
  • Hall AJ, Harrington JM, Waterhouse JA. The Epping jaundice outbreak: a 24 year follow up. J Epidemiol Community Health 1992;46(4):327-8
  • Nichols L. The Epping Jaundice outbreak: mortality after 38 years of follow-up. Int Arch Occup Environ Health 2004;77(8):592-4
  • Martelli A, Carrozzino R, Mattioli F, Brambilla G. DNA damage induced by 4,4'-methylenedianiline in primary cultures of hepatocytes and thyreocytes from rats and humans. Toxicol Appl Pharmacol 2002;182(3):219-25
  • Weisburger EK, Murthy AS, Lilja HS, Lamb JCt. Neoplastic response of F344 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4′-methylenebis(N,N-dimethyl)-benzenamine, 4,4′-oxydianiline, and 4,4′-methylenedianiline. J Natl Cancer Inst 1984;72(6):1457-63
  • Selmi C, Gershwin ME. The role of environmental factors in primary biliary cirrhosis. Trends Immunol 2009;30(8):415-20
  • Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138(10):3525-31
  • Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007;28(2-3):76-84
  • Long SA, Quan C, Van de Water J, Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167(5):2956-63
  • Leung PS, Quan C, Park O, Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003;170(10):5326-32
  • Amano K, Leung PS, Xu Q, Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004;172(10):6444-52
  • Amano K, Leung PS, Rieger R, Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005;174(9):5874-83
  • Wakabayashi K, Lian ZX, Leung PS, Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008;48(2):531-40
  • Wu SJ, Yang YH, Tsuneyama K, Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011;53(3):915-25
  • Rieger R, Leung PS, Jeddeloh MR, Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006;27(1):7-16
  • Naiyanetr P, Butler JD, Meng L, Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 2011;37(3):209-16
  • Leung PS, Rossaro L, Davis PA, Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007;46(5):1436-42
  • Fickert P, Trauner M, Fuchsbichler A, Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 2002;161(6):2019-26
  • Yokoo H, Harwood TR, Racker D, Arak S. Experimental production of Mallory bodies in mice by diet containing 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Gastroenterology 1982;83(1 Pt 1):109-13
  • Zatloukal K, Stumptner C, Fuchsbichler A, p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160(1):255-63
  • Strnad P, Harada M, Siegel M, Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007;132(4):1515-26
  • Harada M, Strnad P, Resurreccion EZ, Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology 2007;45(1):88-96
  • Nakamichi I, Toivola DM, Strnad P, Keratin 8 overexpression promotes mouse Mallory body formation. J Cell Biol 2005;171(6):931-7
  • Hanada S, Snider NT, Brunt EM, Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Gastroenterology 2010;138(4):1607-17
  • Strnad P, Tao GZ, So P, “Toxic memory” via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction. Hepatology 2008;48(3):931-42
  • Zhang-Gouillon ZQ, Yuan QX, Hu B, Mallory body formation by ethanol feeding in drug-primed mice. Hepatology 1998;27(1):116-22
  • Fickert P, Stoger U, Fuchsbichler A, A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007;171(2):525-36
  • Hanada S, Strnad P, Brunt EM, Omary MB. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hepatology 2008;48(3):943-52
  • Preisegger KH, Factor VM, Fuchsbichler A, Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 1999;79(2):103-9
  • Ishikawa T, Factor VM, Marquardt JU, Hepatocyte growth factor (HGF)/c-Met signaling is required for stem cell mediated liver regeneration. Hepatology 2011; Epub ahead of print
  • Apte U, Thompson MD, Cui S, Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 2008;47(1):288-95
  • Beer S, Komatsubara K, Bellovin DI, Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis. PLoS One 2008;3(6):e2493
  • Wang C, Yang W, Yan HX, Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 2012;55(1):108-20
  • Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology 2011;53(3):1023-34
  • Yamazaki Y, Moore R, Negishi M. Nuclear receptor CAR (NR1I3) is essential for DDC-induced liver injury and oval cell proliferation in mouse liver. Lab Invest 2011;91(11):1624-33
  • Fickert P, Fuchsbichler A, Moustafa T, Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009;175(6):2392-405
  • Mair M, Blaas L, Osterreicher CH, JAK-STAT signaling in hepatic fibrosis. Front Biosci 2011;17:2794-811
  • Plum W, Tschaharganeh DF, Kroy DC, Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis. Am J Pathol 2010;176(5):2236-46
  • Fickert P, Thueringer A, Moustafa T, The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab Invest 2010;90(6):844-52
  • Carpenter-Deyo L, Marchand DH, Jean PA, Involvement of glutathione in 1-naphthylisothiocyanate (ANIT) metabolism and toxicity to isolated hepatocytes. Biochem Pharmacol 1991;42(11):2171-80
  • Becker BA, Plaa GL. The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol 1965;7(5):680-5
  • Desmet VJ, Krstulovic B, Van Damme B. Histochemical study of rat liver in alpha-naphthyl isothiocyanate (ANIT) induced cholestasis. Am J Pathol 1968;52(2):401-21
  • Mc LM, Rees KR. Hyperplasia of bile-ducts induced by alpha-naphthyl-iso-thiocyanate: experimental biliary cirrhosis free from biliary obstruction. J Pathol Bacteriol 1958;76(1):175-88
  • Krstulovic B, Van D, Desmet VJ. Comparative histochemical study of rat liver in bile-duct ligation and in alpha-napthyl isothiocyanate (ANIT) intoxication. Am J Pathol 1968;52(2):423-36
  • Xu J, Lee G, Wang H, Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury. Am J Physiol Gastrointest Liver Physiol 2004;287(3):G734-41
  • Kodali P, Wu P, Lahiji PA, ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18. Am J Physiol Gastrointest Liver Physiol 2006;291(2):G355-63
  • Luyendyk JP, Cantor GH, Kirchhofer D, Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2009;296(4):G840-9
  • Sullivan BP, Weinreb PH, Violette SM, Luyendyk JP. The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. Am J Pathol 2010;177(6):2837-49
  • Luyendyk JP, Flanagan KC, Williams CD, Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice. Toxicol Appl Pharmacol 2011;250(3):256-62
  • Sullivan BP, Wang R, Tawfik O, Luyendyk JP. Protective and damaging effects of platelets in acute cholestatic liver injury revealed by depletion and inhibition strategies. Toxicol Sci 2010;115(1):286-94
  • Luyendyk JP, Kassel KM, Allen K, Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis. Am J Pathol 2011;178(3):1117-25
  • Sullivan BP, Cui W, Copple BL, Luyendyk JP. Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice. Toxicol Sci 2012;126(1):267-74
  • Cui YJ, Aleksunes LM, Tanaka Y, Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci 2009;110(1):47-60
  • Tanaka Y, Aleksunes LM, Cui YJ, Klaassen CD. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. Toxicol Sci 2009;108(2):247-57
  • Walker CO, Combes B. Biliary cirrhosis induced by chlorpromazine. Gastroenterology 1966;51(5):631-40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.